An approach for conjugation of (177) Lu- DOTA-SCN- Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patients.
about
Monoclonal Antibody and Fusion Protein Biosimilars Across Therapeutic Areas: A Systematic Review of Published EvidenceBiosimilars for the Treatment of Cancer: A Systematic Review of Published EvidencePhysicochemical Evaluation of Lyophilized Formulation of p-SCN-Bn-DOTA- and p-SCN-Bn-DTPA-rituximab for NHL Radio Immunotherapy.
P2860
An approach for conjugation of (177) Lu- DOTA-SCN- Rituximab (BioSim) & its evaluation for radioimmunotherapy of relapsed & refractory B-cell non Hodgkins lymphoma patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
An approach for conjugation of ...... on Hodgkins lymphoma patients.
@en
type
label
An approach for conjugation of ...... on Hodgkins lymphoma patients.
@en
prefLabel
An approach for conjugation of ...... on Hodgkins lymphoma patients.
@en
P2093
P2860
P1476
An approach for conjugation of ...... on Hodgkins lymphoma patients.
@en
P2093
Arun Malhotra
Atul Sharma
Atul Vasisht
Madhav Prasad Yadav
Parul Thakral
Santosh Kumar Gupta
Suhas Singla
P2860
P304
P407
P577
2014-04-01T00:00:00Z